Published in Healthcare Finance, Tax and Law Weekly, June 14th, 2006
This trend article about Capital University of Medical Sciences, Beijing is an immediate alert from LawRx to identify developing directions of research.
Researchers in People's Republic Of China report, "Cilostazol is a newly developed antiplatelet drug that has been widely applied for clinical use. Its antiplatelet action appears to be mainly related to inhibition of intracellular phosphodiesterase...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly